| Castro, Cesar M |
Massachusetts General Hospital
United States |
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach |
3U01CA279858-03S2 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Caulin, Carlos |
University Of Arizona
United States |
Genetic Alterations That Confer High Risk to Oral Premalignant Lesions |
5R01CA274857-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
John Clifford, Ph.D. |
| Caywood, Emi H |
Nemours Children'S Hospital, Delaware
United States |
Nemours NCI Community Oncology Research Program (NCORP) |
3UG1CA189958-11S1 |
|
Vanessa A. White, M.P.H. |
| Chak, Amitabh |
Case Western Reserve University
United States |
Pathways of Injury and Repair in Barrett's Carcinogenesis |
5P01CA269019-03 |
|
Asad Umar, D.V.M., Ph.D. |
| Chan, Andrew T |
Massachusetts General Hospital
United States |
Precision Prevention Research Program |
5R35CA253185-06 |
|
Asad Umar, D.V.M., Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions |
5U01CA274514-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs |
5U2CCA271895-03 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Chan, Alexandre |
University Of California-Irvine
United States |
Neurotrophic strategy to mitigate chemotherapy-related brain injury |
5R01CA276212-03 |
PAR-21-329 (R01 Clinical Trial Optional) |
John Clifford, Ph.D. |
| Chapkin, Robert Stephen |
Texas A&M Agrilife Research
United States |
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling |
5R01CA244359-05 |
|
Amit Kumar, Ph.D. |
| Chen, Ru |
Baylor College Of Medicine
United States |
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION |
4UH3CA292130-02 |
|
Claire Zhu, Ph.D. |
